Is Eton Pharmaceuticals, Inc. overvalued?

Eton Pharmaceuticals, Inc. (ETON) — key valuation metrics and fundamentals.

No verdict

Price

$58.86

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$1.61B

Dividend yield

0.0%

Return on equity

-5.7%

Sector

Healthcare

Fair value compares ETON's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks